Lv11
88 积分 2023-07-04 加入
AlloSigMA: allosteric signaling and mutation analysis server
5小时前
已完结
AlloSigMA 2: paving the way to designing allosteric effectors and to exploring allosteric effects of mutations
5小时前
已完结
Probing the mechanisms of hydrazide-based HDAC inhibitors binding to HDAC3 using Gaussian accelerated molecular dynamics (GaMD) simulations
1个月前
已完结
Elucidating the structural basis of vitamin B12 derivatives as novel potent inhibitors of PTP1B: Insights from inhibitory mechanisms using Gaussian accelerated molecular dynamics (GaMD) and in vitro study
1个月前
已完结
Fine-Tuned Deep Transfer Learning Models for Large Screenings of Safer Drugs Targeting Class A GPCRs
4个月前
已关闭
Exploring potential GPR55 agonists using virtual screening, molecular docking and dynamics simulation studies
4个月前
已完结
Molecular mechanism underlying effect of D93 and D289 protonation states on inhibitor-BACE1 binding: exploration from multiple independent Gaussian accelerated molecular dynamics and deep learning
5个月前
已完结
In silico prediction of some pharmacokinetic, safety, biological activity and molecular docking studies of 1-piperazine indole hybrid with nicotinic amide and nicotinic acid and their analogues
5个月前
已完结
The GLP-1R as a model for understanding and exploiting biased agonism in next-generation medicines
6个月前
已完结
Comparative Study of Allosteric GPCR Binding Sites and Their Ligandability Potential
6个月前
已完结
Experimental study on explosive boiling mechanism of superheated liquid containing ethanol impurities under rapid depressurization
5个月前
已采纳
Development of efficient methods for prediction of medium to large scale BLEVE pressure in open space
5个月前
已采纳
Structure–Activity Relationship of Sulfonyl Piperazine LpxH Inhibitors Analyzed by an LpxE-Coupled Malachite Green Assay
5个月前
已采纳
Implementing NIH Behavior Change Consortium Treatment Fidelity Recommendations in a Multi-Site Randomized Controlled Trial of an Active Music Engagement Intervention for Young Children with Cancer and Parents
8个月前
已采纳
CCN proteins: opportunities for clinical studies—a personal perspective
8个月前
已采纳
Advocating for rituximab as first-line treatment for NMOSD-AQP4 patients in France: Cost and efficacy considerations
8个月前
已采纳
皖公网安备34019202002308
